CHRONIC WEIGHT MANAGEMENT
Clinical trials for CHRONIC WEIGHT MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new CHRONIC WEIGHT MANAGEMENT trials appear
Sign up with your email to follow new studies for CHRONIC WEIGHT MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New obesity pill shows promise in phase 2 trial
Disease control CompletedThis study tested a new medication called aleniglipron (GSBR-1290) to help people with obesity or overweight lose weight. 85 adults took different doses of the drug or a placebo for 44 weeks, along with diet and exercise. The main goals were to check safety and side effects, and …
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:57 UTC
-
New obesity drug shows promise in Long-Term weight control
Disease control CompletedThis study looked at the long-term safety and effectiveness of HRS-7535 tablets for weight management in 81 adults with obesity. Participants who completed a previous 36-week study continued treatment for an additional 32 weeks. The main goal was to track side effects, while also…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
New pill shows promise for shedding pounds in overweight adults
Disease control CompletedThis study tested a new tablet called ASC30 to help people who are overweight or obese and have related health problems lose weight. About 125 adults took either the study drug or a placebo for 13 weeks. Researchers measured weight loss, waist size, and safety to see if the drug …
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New combo shot aims to boost weight loss in early trial
Symptom relief CompletedThis early-stage study tested whether adding an experimental injection called ASC47 to the weight-loss drug semaglutide is safe and helps with weight management. 28 adults with obesity received either the combination or a placebo. Researchers measured side effects and weight chan…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE1 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC